Evidence that D-1 dopamine receptors contribute to the supersensitive behavioral responses induced by L-dihydroxyphenylalanine in rats treated neonatally with 6-hydroxydopamine

J Pharmacol Exp Ther. 1985 Nov;235(2):287-95.

Abstract

The present investigation supports the hypothesis that functionally supersensitive D-1 dopamine receptors are involved in the self-mutilation behavior (SMB) induced by L-dihydroxyphenylalanine (L-dopa) in rats treated neonatally with 6-hydroxydopamine (6-OHDA). This conclusion is based upon 1) the antagonism of this behavior by SCH-23390, a D-1 antagonist; 2) induction of SMB in neonatal-6-OHDA-treated rats by the D-1 agonist, SKF-38393; 3) the high correlation of the supersensitive locomotor responses to the D-1 agonist with the occurrence of L-dopa-induced SMB; and 4) the inability of the D-2 agonist, LY-171555, to induce SMB in rats treated neonatally with 6-OHDA. The specificity of SCH-23390 and SKF-38393 for the D-1 dopamine receptor was supported by the absence of action of SCH-23390 against locomotor activities induced by LY-171555 and its blockade of SKF-38393-induced locomotion in 6-OHDA-treated rats. Behavioral responses to D-1 and D-2 agonists did not show the same profile in adult and neonatally 6-OHDA-treated rats, providing further support for the view that the age at which dopaminergic neurons are destroyed has differing effects on motor output. Many of the behaviors observed when the D-2 dopamine receptor was activated by LY-171555 were apparent after SKF-38393 in neonatally 6-OHDA-treated rats. Similar behavioral responses to the D-1 and D-2 agonists were also observed in adult 6-OHDA-treated rats.(ABSTRACT TRUNCATED AT 250 WORDS)

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine
  • Analysis of Variance
  • Animals
  • Animals, Newborn
  • Behavior, Animal / drug effects*
  • Benzazepines / pharmacology
  • Dihydroxyphenylalanine / pharmacology*
  • Drug Interactions
  • Ergolines / pharmacology
  • Female
  • Flupenthixol / pharmacology
  • Haloperidol / pharmacology
  • Hydroxydopamines / pharmacology*
  • Levodopa / pharmacology
  • Male
  • Motor Activity / drug effects
  • Oxidopamine
  • Pregnancy
  • Quinpirole
  • Rats
  • Receptors, Dopamine / metabolism*
  • Self Mutilation / chemically induced
  • Stereotyped Behavior / drug effects

Substances

  • Benzazepines
  • Ergolines
  • Hydroxydopamines
  • Receptors, Dopamine
  • Quinpirole
  • Levodopa
  • Dihydroxyphenylalanine
  • 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine
  • Oxidopamine
  • Flupenthixol
  • Haloperidol